| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000016013 |
| Receipt No. | R000018612 |
| Official scientific title of the study | Clinical study of tube administration speed of viscosity modifiered enteral fomula |
| Date of disclosure of the study information | 2015/01/05 |
| Last modified on | 2017/06/22 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Clinical study of tube administration speed of viscosity modifiered enteral fomula | |
| Title of the study (Brief title) | tube administration speed of viscosity modifiered enteral fomula | |
| Region |
|
|
| Condition | ||||||
| Condition | Tube feeding | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | The corelation between in vitro and in vivo examination of administration speed in tube feeding with long catheter example of nasogastric catheter, percutaneous transesophageal catheter,
and jejunal catheter. |
| Basic objectives2 | Others |
| Basic objectives -Others | Comfirmation of clinical side effect. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Administration speed comparing with in vitro study |
| Key secondary outcomes | Change of urinal pH.change of body weight. Frequency of diarrhea and constipation. Change of body temparature. The room temparature. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The objects are administerd viscosity controlled enteral formula.
|
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who undergo tube feeding.The subject who recognized the examination and is able to give the agreement. The patients who is undergoing tube feeding with nasogastric catheter 5 days or longer.
|
|||
| Key exclusion criteria | The patients who are cirtified as contraindication case of this study by attending doctor.
The patients out of indication for tube feeding. The patients have a complication durig the study. |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Naohiro Washizawa |
| Organization | Toho University Omori Medical Center |
| Division name | Nutrition Therapy Center |
| Address | Omori-Nishi6-11-1,Ota-ku,Tokyo |
| TEL | 03-3762-4151 |
| washi@med.toho-u.ac.jp | |
| Public contact | |
| Name of contact person | Naohiro Washizawa |
| Organization | Toho University Omori Medical Center |
| Division name | Nutrition Therapy Center |
| Address | Omori-Nishi6-11-1,Ota-ku,Tokyo |
| TEL | 03-3762-4151 |
| Homepage URL | |
| washi@med.toho-u.ac.jp | |
| Sponsor | |
| Institute | VF researching group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Toho university school of medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Tanashi hospital, Clover hospital, ASAHI KASEI PHARMA CORPORATION |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東邦大学医療センター大森病院、田無病院、クローバーホスピタル |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018612 |